Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and back.

Lung cancer (Amsterdam, Netherlands) - 1 Aug 2003

Franklin Wilbur A, Carbone David P

Abstract excerpt

The complexities of human cancer have frustrated attempts to understand its genetic underpinnings and explain the unpredictable behavior of individual tumors. Advances in robotics and computer science, as well as the sequence data from the human genome project are now allowing us to begin to glean useful information from the simultaneous analysis of thousands of data elements from hundreds of tumors. Through the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Genome Project

Share to Neoplasm Staging

Share to Oligonucleotide Array Sequence Analysis

Share to Pharmacogenetics

Share to Predictive Value of Tests

Source

Identifiers

PMID: 12867073
DOI: 10.1016/s0169-5002(03)00158-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and back.PMID 12867073Read ↗

Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosisSemantic proximity Read ↗

Next-Generation Cancer Phenomics: A Transformative Approach to Unraveling Lung Cancer Complexity and Advancing Precision Medicine.Semantic proximity Read ↗

Molecular testing and personalized treatment of lung cancer.Semantic proximity Read ↗

Exploring AI tools and multi-omics for precision medicine in lung cancer therapy.Semantic proximity Read ↗

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung CancerSemantic proximity Read ↗

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceSemantic proximity Read ↗

Recent Advances in Personalized Lung Cancer MedicineSemantic proximity Read ↗

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity Read ↗

Biomarkers and transcriptome profiling of lung cancer.Semantic proximity Read ↗

Genomic architecture of lung cancers.Semantic proximity Read ↗

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applicationsSemantic proximity Read ↗

Lung Cancer GenomicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.